AIM ImmunoTech Inc.
AIMAMEXHealthcare● Active
$0.52
+$0.00(+0.60%)
Market Cap$1766097
P/E Ratio—
52W High$19.73812
52W Low$0.21
AIM ImmunoTech Inc.（AIM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AIM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.09M | $0.17M | $0.20M | $0.14M | $0.14M |
| Cost of Revenue | $0.34M | $0.03M | $0.04M | $0.00M | $0.85M |
| Gross Profit | ($0.25M) | $0.14M | $0.16M | $0.14M | ($0.71M) |
| Gross Margin %(computed) | -284.09% | 81.76% | 79.21% | 100.00% | -529.63% |
| Operating Expenses | |||||
| R&D Expenses | $3.92M | $6.20M | $10.93M | $6.99M | $7.67M |
| G&A Expenses | $7.70M | $13.71M | $21.14M | $13.07M | $8.67M |
| Total Operating Expenses | $10.28M | $19.91M | $32.08M | $20.06M | $18.12M |
| Operating Income | ($10.53M) | ($19.77M) | ($31.92M) | ($19.92M) | ($18.84M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $3.18M | $5.19M | $1.07M | $0.63M | $0.00M |
| Interest Expense | $0.81M | $0.58M | $0.00M | $0.00M | $0.07M |
| Income Before Tax | ($13.96M) | ($17.32M) | ($28.96M) | ($19.45M) | ($19.13M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($13.96M) | ($17.32M) | ($28.96M) | ($19.45M) | ($19.13M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-8.62 | $-11.22 | $-21.64 | $-14.69 | $-14.67 |
| Wtd Avg Shares | 1.62M | 1.54M | 1.34M | 1.32M | 1.31M |
| EBITDA | ($10.32M) | ($16.49M) | ($28.72M) | ($19.87M) | ($18.29M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解AIM ImmunoTech Inc.
关于AIM ImmunoTech Inc.（AIM）损益表
AIM ImmunoTech Inc.（AIM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AIM实现营收$0.00B，毛利润($0.00B)（毛利率-284.09%），净利润($0.01B)（净利率-15861.36%）。
常见问题
AIM · 4 问AIM ImmunoTech Inc.（AIM）2025财年营收为$0.00B，同比down48.2%。
AIM revenueAIM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08